Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 25.54
+0.69 (2.78%)
At close: Dec 4, 2025
SHA:601089 Revenue
Beijing Foyou Pharma CO.,LTD had revenue of 886.63M CNY in the quarter ending September 30, 2025, a decrease of -0.55%. This brings the company's revenue in the last twelve months to 3.42B, down -0.13% year-over-year. In the year 2024, Beijing Foyou Pharma CO.,LTD had annual revenue of 3.45B with 3.17% growth.
Revenue (ttm)
3.42B
Revenue Growth
-0.13%
P/S Ratio
3.44
Revenue / Employee
938.32K
Employees
3,644
Market Cap
11.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.45B | 106.01M | 3.17% |
| Dec 31, 2023 | 3.34B | 99.48M | 3.07% |
| Dec 31, 2022 | 3.24B | 402.44M | 14.18% |
| Dec 31, 2021 | 2.84B | 302.37M | 11.93% |
| Dec 31, 2020 | 2.54B | 110.67M | 4.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |
| Shanghai United Imaging Healthcare | 12.20B |